FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

DAVIS JAMES L
2. Issuer Name and Ticker or Trading Symbol

ProUroCare Medical Inc. [ PUMD ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

6446 FLYING CLOUD DR
3. Date of Earliest Transaction (MM/DD/YYYY)

1/7/2009
(Street)

EDEN PRAIRIE, MN 55344
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, $0.00001 par value                  187161   D    
Common stock, $0.00001 par value   (8) 1/7/2009     C (6)    79741   A   (6) 79741   D    
Common Stock, $0.00001 par value   (8) 1/7/2009     C (7)    314846   A   (7) 314846   D    
Common Stock, $0.00001 par value   (8) 1/7/2009     C (9)    224890   A   (9) 224890   D    
Common Stock, $0.00001 par value   (8) 1/7/2009     C (9)    74964   A   (9) 74964   I   Held by "Davis & Associates 401K PSP"   (2)
Common Stock, $0.00001 par value   (8) 1/7/2009     C (9)    37482   A   (9) 37482   I   Held by "Davis & Associates Inc."   (2)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants   $5.00                     (1) 2/28/2010   Common stock, $0.00001 par value   15625     15625   D    
Warrants   $5.00                     (1) 3/21/2010   Common stock, $0.00001 par value   1702     1702   D    
Warrants   $5.00                     (1) 12/27/2012   Common stock, $0.00001 par value   5800     5800   D    
Warrants   $1.50                     (1) 4/3/2013   Common stock, $0.00001 par value   25000     25000   D    
Warrants   $5.00                     (1) 12/27/2012   Common stock, $0.00001 par value   6050     6050   I   Held by "Davis & Associates Inc. 401K PSP"   (2)
Warrants   $5.00                     (1) 12/27/2012   Common stock, $0.00001 par value   700     700   I   Held by "Davis & Associates Inc."   (2)
Warrants   $.50                     (1) 12/31/2012   Common stock, $0.00001 par value   30000     30000   D    
Warrants   $.70                     (1) 12/31/2012   Common stock, $0.00001 par value   30000     30000   D    
Warrants   $.70                     (1) 12/31/2012   Common stock, $0.00001 par value   10000     10000   I   Held by "Davis & Associates Inc. 401K PSP"   (2)
Warrants   $.70                     (1) 12/31/2012   Common stock, $0.00001 par value   5000     5000   I   Held by "Davis & Associates Inc."   (2)
Warrant   $1.00                     (1) 12/31/2012   Common stock, $0.00001 par value   10000     10000   D    
Warrants   $1.00                     (1) 12/31/2012   Common stock, $0.00001 paar value   10000     10000   D    
Convertible Promissory Note   $.70                     (3) 3/16/2010   Common stock, $0.00001 par value   $95000     $95000   D    
Convertible Promissory Note   $.70                     (1) 1/14/2009   (4) Common stock, $0.00001 par value   $150000   (4)   $150000   D    
Warrants   $1.50                     (1) 9/25/2013   Common stock, $0.00001 par value   100000     100000   D    
Convertible Promissory Note   $.70                     (1) 12/31/2008   (5) Common stock, $0.00001 par value   $37500     $37500   D    
Warrants   $1                     (1) 12/31/2012   Common stock, $0.00001 par value   10000     10000   D    
Warrants   $2.00                   10/31/2009   10/31/2013   Common stock, $0.00001 par value   16667     16667   D    
10% Unsecured Convertible Subordinated Debenture   $3.00   1/7/2009   (6)         200000      (6) 2/16/2009   Common stock, $0.00001 par value   $200000   $200000   (6) $0   D    
Convertible Promissory Notes   $.50   1/7/2009           142500      (7) 6/27/2009   Common stock, $0.00001 par value   $142500   $142500   (7) $0   D    
Convertible Promissory Notes   $.70   1/7/2009           142500      (9) 6/27/2009   Common stock, $0.00001 par value   $142500   $142500   (9) $0   D    
Convertible Promissory Notes   $.70   1/7/2009           47500    2/6/2009   (9) 6/27/2009   Common stock, $0.00001 par value   $47500   $47500   (9) $0   I   Held by "Davis & Associates Inc. 401K PSP"   (2)
Convertible Promissory Notes   $.70   1/7/2009           23750      (9) 6/27/2009   Common stock, $0.00001 par value   $23750   $23750   (9) $0   I   Held by "Davis & Associates Inc."   (2)
Warrant   (8) $1.30   1/7/2009     (7)    314846       2/6/2009   1/7/2014   Common stock, $0.00001 par value   314846     (7) 314846   D    
Warrants   (8) $1.30   1/7/2009     (9)    224890       2/6/2009   1/7/2014   Common stock, $0.00001 par value   224890     (9) 224890   D    
Warrants   (8) $1.30   1/7/2009     (9)    74964       2/6/2009   1/7/2014   Common stock, $0.00001 par value   74964     (9) 74964   I   Held by "Davis & Associates Inc. 401K PSP"   (2)
Warrants   (8) $1.30   1/7/2009     (8)    37482       2/6/2009   1/7/2014   Common stock, $0.00001 par value   37482     (7) 37482   I   Held by "Davis & Associates Inc."   (2)

Explanation of Responses:
( 1)  Currently exercisable
( 2)  Reporting person is the Sole owner of Davis & Associates Inc. and has sole voting power.
( 3)  The notes and accrued interest theron will automatically convert into common stock on February 6, 2009 at $0.70 per share.
( 4)  The reporting person loaned $150,000 to the issuer pursuant to a convertible promissory note. The note and accrued interest thereon is convertible into common stock at $0.70 per share. The note and the accrued interest become due and payable if the holder chooses not to convert the note by January 14, 2009.
( 5)  The promissory note was due on December 31, 2008, but remains unpaid. Reporting person may convert the promissory note into common stock until such time as the note is paid.
( 6)  The principal amount of the promissory note and the accrued interest thereon were automatically converted into common stock at $3.00 per share upon the effectiveness of the issuer's public offering on January 7, 2009.
( 7)  The principal amount of the promissory note and the accrued interest thereon were automatically converted into units at a price of $0.50 per unit consisting of one share of common stock and one warrant to purchase common stock upon the effectiveness of the issuer's public offering on January 7, 2009.
( 8)  The common stock and warrants were issued together as a Unit. Each unit consists of one share of $0.00001 par value common stock and one redeemable five-year warrant to purchase one share of common stock at $1.30 per share. The warrants become exercisable and separately transferable from the shares of common stock on February 6, 2009.
( 9)  The principal amount of the promissory note and the accrued interest thereon were automatically converted into units at a price of $0.70 per unit consisting of one share of common stock and one warrant to purchase common stock upon the effectiveness of the issuer's public offering on January 7, 2009.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
DAVIS JAMES L
6446 FLYING CLOUD DR
EDEN PRAIRIE, MN 55344

X


Signatures
Richard B. Thon by power of attorney 1/9/2009
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more ProUroCare Medical (CE) Charts.
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more ProUroCare Medical (CE) Charts.